19
IRUS Total
Downloads

Monoclonal antibodies against metzincin targets

File Description SizeFormat 
pdf with table.pdfAccepted version1.25 MBAdobe PDFView/Open
Title: Monoclonal antibodies against metzincin targets
Authors: Santamaria, S
De Groot, R
Item Type: Journal Article
Abstract: The metzincin clan of metalloproteinases includes the MMP, disintegrin and metalloproteinase (ADAM) and ADAM with thrombospondin motifs families, which cleave extracellular targets in a wide range of (patho)physiological processes. Antibodies constitute a powerful tool to modulate the activity of these enzymes for both therapeutic and research purposes. In this review, we give an overview of monoclonal antibodies (mAbs) that have been tested in preclinical disease models, human trials and important studies of metzincin structure and function. Initial attempts to develop therapeutic small molecule inhibitors against MMPs were hampered by structural similarities between metzincin active sites and, consequently, off‐target effects. Therefore, more recently, mAbs have been developed that do not bind to the active site but bind to surface‐exposed loops that are poorly conserved in closely related family members. Inhibition of protease activity by these mAbs occurs through a variety of mechanisms, including (i) barring access to the active site, (ii) disruption of exosite binding, and (iii) prevention of protease activation. These different modes of inhibition are discussed in the context of the antibodies' potency, selectivity and, importantly, the effects in models of disease and clinical trials. In addition, various innovative strategies that were used to generate anti‐metzincin mAbs are discussed.
Issue Date: 31-Jan-2019
Date of Acceptance: 16-Feb-2018
URI: http://hdl.handle.net/10044/1/57289
DOI: https://doi.org/10.1111/bph.14186
ISSN: 1476-5381
Publisher: Wiley
Start Page: 52
End Page: 66
Journal / Book Title: British Journal of Pharmacology
Volume: 176
Issue: 1
Copyright Statement: © 2018 Owner. This is the accepted version of the following article: Santamaria, S., and Groot, R. ( 2019) Monoclonal antibodies against metzincin targets. British Journal of Pharmacology, 176: 52– 66. https://doi.org/10.1111/bph.14186., which has been published in final form at https://doi.org/10.1111/bph.14186.
Sponsor/Funder: Wellcome Trust
Funder's Grant Number: PS3126_WMEH
Keywords: Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
TYPE-1 MATRIX-METALLOPROTEINASE
DISINTEGRIN-LIKE DOMAIN
PLASMA PROTEIN-A
IN-VIVO
SELECTIVE-INHIBITION
MURINE MODEL
GELATINASE-B
1-MATRIX METALLOPROTEINASE
ANTI-ADAMTS-5 ANTIBODY
PROTEOLYTIC ACTIVITY
Pharmacology & Pharmacy
1115 Pharmacology and Pharmaceutical Sciences
Publication Status: Published
Online Publication Date: 2018-02-27
Appears in Collections:Department of Immunology and Inflammation